The present invention is directed to cyanomethyl derivatives that are inhibitors of cysteine protease, in particular, cathepsin B, K, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

 
Web www.patentalert.com

< Soft tissue implants and anti-scarring agents

< Azolidinone-vinyl fused-benzene derivatives

> Chemical compounds

> Amido compounds and their use as pharmaceuticals

~ 00269